Kamarck M E, Elting J J, Hart J T, Goebel S J, Rae P M, Nothdurft M A, Nedwin J J, Barnett T R
Proc Natl Acad Sci U S A. 1987 Aug;84(15):5350-4. doi: 10.1073/pnas.84.15.5350.
Genomic DNA and mRNA from the adenocarcinoma cell line LoVo were used to generate L-cell transfectants and a bacteriophage lambda gt11 cDNA clone that express epitopes of carcinoembryonic antigen (CEA). Primary and secondary L-cell transfectants expressing CEA were selected with a fluorescence-activated cell sorter (FACS). These transfectants, including some clones that were selected for high-level CEA expression by multiple rounds of FACS sorting, express a surface protein of 150 kDa that reacts with all anti-CEA antibodies tested. In parallel, a cDNA library of LoVo poly(A)+ RNA was constructed in lambda gt11 and fusion proteins were screened with polyclonal antisera against CEA. One positive clone, lambda cLV7, was identified that hybridized specifically to transfectant DNA. The nucleic acid sequence of the cDNA insert (cLV7) contained two regions of extensive internal homology, with greater than 70% identity at the amino acid level. cLV7 hybridized to three mRNA species of LoVo cells and to a predominant mRNA of the CEA-expressing transfectants. Hybridization of cLV7 to restriction endonuclease-digested genomic DNA of colon carcinoma cells, normal human cells, and human-mouse somatic cell hybrids revealed the presence of multiple hybridizing bands, one of which was present in transfectant cells. These CEA-related sequences are not rearranged in tumors and, by somatic cell hybrid analysis, were mapped to human chromosome 19.
来自腺癌细胞系LoVo的基因组DNA和mRNA被用于生成表达癌胚抗原(CEA)表位的L细胞转染子和噬菌体λgt11 cDNA克隆。通过荧光激活细胞分选仪(FACS)筛选出表达CEA的原代和二代L细胞转染子。这些转染子,包括一些通过多轮FACS分选筛选出的高表达CEA的克隆,表达一种150 kDa的表面蛋白,该蛋白能与所有测试的抗CEA抗体发生反应。同时,构建了LoVo poly(A)+ RNA在λgt11中的cDNA文库,并用抗CEA多克隆抗血清筛选融合蛋白。鉴定出一个阳性克隆λcLV7,它能与转染子DNA特异性杂交。cDNA插入片段(cLV7)的核酸序列包含两个广泛的内部同源区域,氨基酸水平上的同一性大于70%。cLV7与LoVo细胞的三种mRNA以及表达CEA的转染子的一种主要mRNA杂交。cLV7与经限制性内切酶消化的结肠癌细胞、正常人细胞和人-鼠体细胞杂种的基因组DNA杂交,显示存在多条杂交带,其中一条存在于转染子细胞中。这些与CEA相关的序列在肿瘤中未发生重排,通过体细胞杂种分析,它们被定位到人类19号染色体上。